Impact Biomedical IBO
NYSE IBO
$5.46 -0.14 (-2.50%)
As of: Oct 1, 2026 · 3:57 PM EDT

Impact Biomedical (IBO) Revenue (2022 - 2026)

Updated

Impact Biomedical's Revenue was $3,000 in Q2 2026, down 57.1% from $7,000 a year earlier and down 57.1% from the prior quarter.

Analysis

Impact Biomedical (IBO) Revenue (2022 - 2026) Analysis & Trends

On a trailing twelve-month basis, Impact Biomedical's Revenue was $35,000 through Jun 30, 2026, down 38.6% year-over-year; for FY2022, it came in at $50,000.

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Revenue (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn 25.31 Bn
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn 16.99 Bn
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn 16.61 Bn
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn 14.41 Bn
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn 15.38 Bn
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn 10.05 Bn
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn 7.80 Bn
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn 15.03 Bn
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn 3.33 Bn
10 Impact Biomedical 598.41 Mn 601.61 Mn 2,000.00 3,000.00
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 3,000.00
Mar 31, 2026 7,000.00
Sep 30, 2025 18,000.00
Jun 30, 2025 7,000.00
Jun 30, 2022 50,000.00
API Access

Impact Biomedical Revenue API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=revenue&ticker=IBO&period=max&api_key=YOUR_API_KEY